drugset / Trial / NCT01704638

Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes

NCT01704638

Phase 1 Completed 14 enrolled Karolinska Institutet
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The investigators will compare plasma kinetics of two marker drugs in individuals with different genetic variations in the MDR1-gene. The hypothesis is that one group will have higher exposure than the other.

Timeline

Start
2008-08
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified
Subject Fluvoxamine Unknown

Indications